GlassScriptPhysician profile
Joseph Joel Abrew
NPI 1780752386
$1,468.41
in general payments reported to CMS, 2019-2025
8 companies · $433 in 2025
The $433 reported for 2025 was more than what 89% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $179 · 2021: $71.85 · 2022: $20.96 · 2023: $505 · 2024: $118 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $597 · Food and Beverage: $444 · Charitable Contribution: $15.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $597.32 |
| Food and Beverage | $443.97 |
| Charitable Contribution | $15.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $744.45 | 2020-2025 | Opalescence |
| Dentsply Sirona INC | $227.04 | 2019-2025 | Suresmile, Midwest, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Orapharma, A Division of Bausch Health US, LLC | $171.36 | 2019-2023 | Ossix Plus |
| Envista Holdings Corporation | $83.64 | 2024-2025 | K3, Spark |
| Nobel Biocare USA | $77.31 | 2023 | Nobelactive |
| Ormco Corporation | $77.31 | 2023 | Spark |
| 3m Company | $71.85 | 2021 | |
| Kulzer, LLC | $15.45 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Abrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.